RenaissanceRe (RNR) Set to Release Earnings Tomorrow: What to Anticipate
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 27 2025
0mins
Should l Buy RNR?
Source: Yahoo Finance
Earnings Report Overview: RenaissanceRe is set to report earnings, having previously exceeded revenue expectations by 8.7% last quarter with revenues of $3.21 billion, a 13.4% year-on-year increase.
Analyst Expectations: For the upcoming quarter, analysts predict a 26.7% decline in revenue to $2.91 billion and adjusted earnings of $9.50 per share, with recent estimates remaining stable.
Peer Performance Insights: Competitors like Stewart Information Services and First American Financial have reported strong revenue growth, indicating mixed performance within the insurance sector.
Market Context: The insurance sector has generally underperformed recently, with RenaissanceRe's share price down 2.7% over the past month, while analysts maintain a price target of $282.86 against the current price of $243.44.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy RNR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on RNR
Wall Street analysts forecast RNR stock price to fall
11 Analyst Rating
3 Buy
7 Hold
1 Sell
Hold
Current: 310.900
Low
267.00
Averages
308.36
High
455.00
Current: 310.900
Low
267.00
Averages
308.36
High
455.00
About RNR
RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance, focused on aligning risk with capital. It offers property, casualty, and specialty reinsurance, along with certain insurance solutions, primarily through intermediaries. It has two reportable segments: Property and Casualty and Specialty. The Property segment includes catastrophe reinsurance, primarily excess of loss and retrocessional coverage for natural and man-made disasters, as well as other property business such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional multi-line business. The Casualty and Specialty segment encompasses reinsurance activities across a range of complex, longer-tail risk categories, including general casualty, professional liability, credit, and other specialty lines of reinsurance. The Company combines data, technology, and the ability to deliver risk solutions and capacity through owned and managed partner balance sheets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
RenaissanceRe Increases Quarterly Dividend to $0.41
- Dividend Increase: RenaissanceRe has raised its quarterly dividend from $0.40 to $0.41 per share, marking the 31st consecutive year of dividend increases since its IPO, which underscores the company's strong financial performance and commitment to shareholders.
- Share Repurchase Program: The Board approved a $750 million share repurchase program, allowing for repurchases through open market and privately negotiated transactions, which is expected to enhance earnings per share and shareholder value, reflecting prudent capital management.
- Dividend Payment Schedule: The new dividend will be payable on March 31, 2026, to shareholders of record on March 13, 2026, ensuring timely returns for investors and further boosting investor confidence.
- Company Overview: Established in 1993, RenaissanceRe is a global provider of reinsurance and insurance, specializing in matching desirable risk with efficient capital, with offices in multiple countries, highlighting its extensive global operations and market influence.
See More
Citi Downgrades RenaissanceRe to Neutral Amid Growth Concerns
- Rating Downgrade: Citi downgraded RenaissanceRe from Buy to Neutral, reflecting a cautious outlook as the company prioritizes return on equity stability over revenue growth, indicating potential challenges ahead.
- Stock Movement: RenaissanceRe's stock dipped 1.5% in Monday trading, with its valuation multiple rising from approximately 6x to over 8x in the past six months, suggesting a market reassessment of its future prospects.
- Competitive Pressures: Analyst Matthew Heimermann noted that increasing competition in core property lines may necessitate continued underwriting discipline, thereby limiting growth potential and EPS prospects in the intermediate term.
- Buyback Support: Despite these challenges, stock buyback activity is expected to support the stock price, with Citi's updated Q1 2026 EPS estimate increasing from $7.29 to $7.69, reflecting the company's proactive capital return strategy.
See More
RENAISSANCERE HOLDINGS LTD: UBS Increases Target Price from $280 to $312
Company Overview: Renaissance Holdings Ltd. has announced a significant increase in its target price.
New Target Price: The target price has been raised to $312 from a previous price of $280.
See More
RenaissanceRe Holdings (RNR.US) Officer Plans to Sell $4.43 Million in Common Stock via Form 144 Amendment
- Stock Sale Announcement: Officer Ross Curtis of Renaissance Re Holdings intends to sell 15,000 shares of its common stock.
- Market Value: The total market value of the shares being sold is approximately $4.43 million.
See More
RenaissanceRe Q4 Earnings Exceed Expectations
- Earnings Beat: RenaissanceRe reported a Q4 non-GAAP EPS of $13.34, surpassing expectations by $2.93, which reflects the company's strong profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.97 billion in Q4, marking a 29.7% year-over-year increase and exceeding forecasts by $1.3 billion, indicating robust competitive positioning and business expansion capabilities.
- Undervalued Preferred Stocks: Market analysis suggests that RenaissanceRe's preferred stocks are undervalued, potentially offering investors a compelling opportunity, highlighting the company's advantages in capital structure.
- Positive Future Outlook: With ongoing growth in the insurance and reinsurance markets, analysts maintain an optimistic outlook for RenaissanceRe's future performance, which is expected to further enhance shareholder returns and market share.
See More
RenaissanceRe Q4 Earnings Announcement Scheduled
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.
See More
RenaissanceRe Increases Quarterly Dividend to $0.41
- Dividend Increase: RenaissanceRe has raised its quarterly dividend from $0.40 to $0.41 per share, marking the 31st consecutive year of dividend increases since its IPO, which underscores the company's strong financial performance and commitment to shareholders.
- Share Repurchase Program: The Board approved a $750 million share repurchase program, allowing for repurchases through open market and privately negotiated transactions, which is expected to enhance earnings per share and shareholder value, reflecting prudent capital management.
- Dividend Payment Schedule: The new dividend will be payable on March 31, 2026, to shareholders of record on March 13, 2026, ensuring timely returns for investors and further boosting investor confidence.
- Company Overview: Established in 1993, RenaissanceRe is a global provider of reinsurance and insurance, specializing in matching desirable risk with efficient capital, with offices in multiple countries, highlighting its extensive global operations and market influence.
See More
Citi Downgrades RenaissanceRe to Neutral Amid Growth Concerns
- Rating Downgrade: Citi downgraded RenaissanceRe from Buy to Neutral, reflecting a cautious outlook as the company prioritizes return on equity stability over revenue growth, indicating potential challenges ahead.
- Stock Movement: RenaissanceRe's stock dipped 1.5% in Monday trading, with its valuation multiple rising from approximately 6x to over 8x in the past six months, suggesting a market reassessment of its future prospects.
- Competitive Pressures: Analyst Matthew Heimermann noted that increasing competition in core property lines may necessitate continued underwriting discipline, thereby limiting growth potential and EPS prospects in the intermediate term.
- Buyback Support: Despite these challenges, stock buyback activity is expected to support the stock price, with Citi's updated Q1 2026 EPS estimate increasing from $7.29 to $7.69, reflecting the company's proactive capital return strategy.
See More
RENAISSANCERE HOLDINGS LTD: UBS Increases Target Price from $280 to $312
Company Overview: Renaissance Holdings Ltd. has announced a significant increase in its target price.
New Target Price: The target price has been raised to $312 from a previous price of $280.
See More
RenaissanceRe Holdings (RNR.US) Officer Plans to Sell $4.43 Million in Common Stock via Form 144 Amendment
- Stock Sale Announcement: Officer Ross Curtis of Renaissance Re Holdings intends to sell 15,000 shares of its common stock.
- Market Value: The total market value of the shares being sold is approximately $4.43 million.
See More
RenaissanceRe Q4 Earnings Exceed Expectations
- Earnings Beat: RenaissanceRe reported a Q4 non-GAAP EPS of $13.34, surpassing expectations by $2.93, which reflects the company's strong profitability and boosts investor confidence.
- Significant Revenue Growth: The company achieved revenues of $2.97 billion in Q4, marking a 29.7% year-over-year increase and exceeding forecasts by $1.3 billion, indicating robust competitive positioning and business expansion capabilities.
- Undervalued Preferred Stocks: Market analysis suggests that RenaissanceRe's preferred stocks are undervalued, potentially offering investors a compelling opportunity, highlighting the company's advantages in capital structure.
- Positive Future Outlook: With ongoing growth in the insurance and reinsurance markets, analysts maintain an optimistic outlook for RenaissanceRe's future performance, which is expected to further enhance shareholder returns and market share.
See More
RenaissanceRe Q4 Earnings Announcement Scheduled
- Earnings Release Date: RenaissanceRe is set to announce its Q4 earnings on February 3rd after market close, with a consensus EPS estimate of $10.41, reflecting a 29.2% year-over-year growth, indicating sustained profitability.
- Revenue Expectations Decline: Despite the optimistic EPS outlook, the revenue estimate stands at $1.67 billion, representing a 27.1% year-over-year decline, highlighting potential challenges in the market environment and business fluctuations.
- Historical Performance: Over the past two years, RenaissanceRe has beaten EPS estimates 88% of the time and revenue estimates 63% of the time, demonstrating the company's reliability in earnings forecasts and market confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 14 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, reflecting analysts' optimistic outlook on the company's future performance.
See More
